Update on the clinical utility of once-daily tacrolimus in the management of transplantation

Update on the clinical utility of once-daily tacrolimus in the management of transplantation

Jane Revollo Department of Pharmacy, Jackson Memorial Hospital, University of Miami Leonard M Miller School of Medicine Miami, FL, USAThe review by Posadas Salas and Srinivas of the clinical utility of once-daily tacrolimus formulations in the management of transplant patients1 was...

Full description

Bibliographic Details
Main Author:	Revollo J
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-05-01
Series:	Drug Design, Development and Therapy
Online Access:	http://www.dovepress.com/letter-update-on-the-clinical-utility-of-once-daily-tacrolimus-in-peer-reviewed-article-DDDT

Similar Items

Update on the clinical utility of once-daily tacrolimus in the management of transplantation
by: Posadas Salas MA, et al.
Published: (2014-09-01)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
by: Jong Man Kim, et al.
Published: (2021-09-01)

Intestinal Permeability in Patients Early after Kidney Transplantation Treated with Two Different Formulations of Once-Daily Tacrolimus
by: Aureliusz Kolonko, et al.
Published: (2023-05-01)

Effects of Late Conversion from Twice-Daily to Once-Daily Slow Release Tacrolimus on the Insulin Resistance Indexes in Kidney Transplant Patients
by: Valeria Cademartori, et al.
Published: (2021-02-01)

The effect of Maintenance Treatment with Twice-daily or Prolonged Once-daily Tacrolimus Formulation on Visual Evoked Potentials in Stable Kidney Transplant Recipients
by: Aureliusz Kolonko, et al.
Published: (2020-06-01)

Effect of <i>CYP3A5</i> on the Once-Daily Tacrolimus Conversion in Stable Liver Transplant Patients
by: Jong Man Kim, et al.
Published: (2020-09-01)

Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus
by: Yuichiro Okumura, MD, et al.
Published: (2017-09-01)

Clinically useful limited sampling strategy to estimate area under the concentration-time curve of once-daily tacrolimus in adult Japanese kidney transplant recipients.
by: Ryuto Nakazawa, et al.
Published: (2019-01-01)

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
by: Doesch AO, et al.
Published: (2013-10-01)

Real-World Administration of Once-Daily MeltDose<sup>®</sup> Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation
by: Katharina Willuweit, et al.
Published: (2020-12-01)

Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus
by: Gantar K, et al.
Published: (2020-09-01)

Tacrolimus dose adjustment is not necessary in dose to dose conversion from a twice daily to a prolonged release once daily dose form
by: Kanitha Tiankanon, et al.
Published: (2022-06-01)

Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study
by: Magali Giral, et al.
Published: (2024-04-01)

Impact of Once- Versus Twice-Daily Tacrolimus Dosing on Medication Adherence in Stable Renal Transplant Recipients: A Canadian Single-Center Randomized Controlled Trial
by: Theone S. E. Paterson, et al.
Published: (2019-08-01)

Tacrolimus for the management of psoriasis: clinical utility and place in therapy
by: Malecic N, et al.
Published: (2016-12-01)

Bioequivalence of twice-daily oral tacrolimus in transplant recipients: More evidence for consensus?
by: Simon Ball
Published: (2017-11-01)

Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients
by: Max M. Maurer, et al.
Published: (2022-01-01)

Once-daily medications for the pharmacological management of ADHD in adults
by: Oleg v Tcheremissine, et al.
Published: (2009-05-01)

Once-Daily MMX Mesalamine in the Management of Ulcerative colitis
by: Wojciech Blonski, et al.
Published: (2011-01-01)

Clinical utility and consumer considerations for the use of once-daily nevirapine extended release for HIV infection treatment
by: Pefura Yone EW, et al.
Published: (2012-12-01)

Comparison of tacrolimus and cyclosporine for immunosuppression after renal transplantation: An updated systematic review and meta-analysis
by: Anoush Azarfar, et al.
Published: (2018-01-01)

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
by: Melissa M. Toyos
Published: (2019-03-01)

Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives
by: Pierre Costa, et al.
Published: (2009-04-01)

Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD
by: D&rsquo;Urzo A
Published: (2013-08-01)

Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD.
by: Price, D, et al.
Published: (2011)

Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis
by: Rakieh C, et al.
Published: (2014-04-01)

A Prediction Model for Tacrolimus Daily Dose in Kidney Transplant Recipients With Machine Learning and Deep Learning Techniques
by: Qiwen Zhang, et al.
Published: (2022-05-01)

Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy
by: Mody R, et al.
Published: (2013-04-01)

Clinical Significance of the Cellular Pharmacodynamics of Tacrolimus in Living-Donor Liver Transplantation
by: Abuduxukuer Mijiti, et al.
Published: (2009-05-01)

Fertility of dairy cows milked once daily or twice daily in New Zealand
by: J.M.D.R. Jayawardana, et al.
Published: (2022-11-01)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
by: Petersen AB, et al.
Published: (2013-06-01)

Management of scrotal pruritus with topical roflumilast 0.3% once daily treatment
by: Paul S. Yamauchi, MD, PhD
Published: (2024-05-01)

Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine
by: Daniel B Zandman, et al.
Published: (2009-03-01)

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

Gut microbiota and tacrolimus dosing in kidney transplantation.
by: John R Lee, et al.
Published: (2015-01-01)

Tacrolimus-induced Ascites after Liver Transplant
by: M Hosseini, et al.
Published: (2018-04-01)

Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trial
by: Balk JM, et al.
Published: (2015-08-01)

Role of fludrocortisone in the management of tacrolimus-induced hyperkalemia in a renal transplant recipient
by: V Sivakumar, et al.
Published: (2014-01-01)

Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective Study
by: Rémi Lenain, et al.
Published: (2021-10-01)

Pharmacogenetics may influence tacrolimus daily dose, but not urinary tubular damage markers in the long-term period after renal transplantation
by: Stefanović Nikola Z., et al.
Published: (2015-01-01)